Clinical Trial Update: Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating efficacy and safety of S 44819 after a recent ischemic stroke; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Recovery
• Stroke

Drugs mentioned

• S 44819

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Post Stroke Recovery | Phase 2 | Status: COMPLETED